STOCK TITAN

Vanguard realigns holdings; reports 0 Avantor shares (AVTR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Avantor Inc: The Vanguard Group reports zero beneficial ownership of Common Stock following internal realignment

The Vanguard Group filed Amendment No. 5 to a Schedule 13G/A reporting 0 shares and 0% beneficial ownership of Avantor Inc common stock. The filing states an internal realignment caused certain subsidiaries to report beneficial ownership separately in reliance on SEC Release No. 34-39538.

Positive

  • None.

Negative

  • None.

Insights

Disaggregation leaves The Vanguard Group showing no beneficial ownership for Avantor common stock.

The amendment documents that, after an internal realignment, certain Vanguard subsidiaries now report holdings separately under SEC Release No. 34-39538. The filing reports 0 shares and 0% beneficial ownership for The Vanguard Group in Avantor common stock.

Cash-flow treatment and any subsidiary-level holdings are not listed in this excerpt; subsequent filings by the reporting subsidiaries may show beneficial positions. Changes here are administrative and do not indicate market trades by Avantor.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does Amendment No. 5 to the Schedule 13G/A for AVTR state?

It states The Vanguard Group reports 0 shares and 0% beneficial ownership of Avantor common stock. The filing cites an internal realignment and reliance on SEC Release No. 34-39538 that disaggregated certain subsidiaries' reporting.

Does this filing mean Vanguard sold all its Avantor shares?

No. The filing attributes the change to an internal realignment that separates subsidiary reporting under SEC Release No. 34-39538. It reports 0 shares for The Vanguard Group entity, but does not disclose subsidiary-level holdings or transactions in this excerpt.

Who signed the amendment and when was it signed?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, with a signature date of 03/26/2026. The form also references the realignment effective January 12, 2026 in its explanatory comment.

Will this amendment change Avantor's shareholder register or voting outcomes?

The filing is a reporting change for The Vanguard Group's disclosure and lists 0 shares for that filer. It does not alter Avantor's shareholder register or voting arrangements directly; any voting interest would depend on holdings reported by the disaggregated subsidiaries.
Avantor

NYSE:AVTR

View AVTR Stock Overview

AVTR Rankings

AVTR Latest News

AVTR Latest SEC Filings

AVTR Stock Data

5.25B
656.41M
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
RADNOR